Executive Summary
=================

1. Introduction
---------------

Hypertension guidelines, which have existed for many years and primarily used in the USA, Canada and Great Britain, are now becoming an issue in Germany. Strong efforts are presently underway for a German version comparable to the guidelines developed for the aforementioned countries. In the course of the health reform the Code of Social Law V (SGB V) confirmed by the coordination committee in § 137 e, it was determined that evidence based guidelines have to be made. The development of guidelines is a part of the implementation system. The AWMF (work community of the scientific medical subject companies) provides the guidelines <http://leitlinien.net> for the treatment of various syndromes under a simple search mask on the Internet.

The following definitions are given to the legally necessary distinction of guidelines:

Guidelines are systematically developed with representations and recommendations which have to be supported with the purpose. They should be formulated as to assist physicians and patients through recommendations about adequately informing the sick person (prevention, diagnostics, therapy and after-care) under specific medical circumstances.

Guidelines are rules of action for a legal, professional or institutionally legitimised branch or organisation. Such guidelines represent the upstanding integrity of such organizations. Non observation or intentional non compliance with such guidelines can lead to defined sanctions by regulatory agencies. In Germany guidelines (\"Richtlinien\") are different from \"guidelines\" (\"Leitlinien\") considerably with regard to this liability. This distinction is specific for the German and European linguistic area.

The implementation of guidelines is difficult to monitor and not solved by a special method. The AWMF has worked out a concept, in cooperation with representatives of the G7 states in Leeds, Castle, incorporating questions of measuring health outcomes. The guidelines of the AWMF are \"a live development system that uses Plan Do Cheque Act cycles (PDCA cycles) and the aid of the quality management, such as employs implementation strategies like motivation, overcoming of barriers and continuous, systematic further education\".

The clearinghouse for guidelines of the AWMF is working for quality safeguarding (ÄZQ) on the design of a study together with the permanent committee for guidelines of the AWMF and with the medical authority for the evaluation of the quality of the guidelines in the AWMF at present. The financing is still undetermined; however, negotiations are currently underway with external fund givers.

The task of this HTA report is to represent the publications concerning the guidelines for hypertension in Germany and to analyse these publications with regard to its application and distribution.

2. Question
-----------

The following questions shall be answered in particular:

How much are the guidelines used concerning hypertension?Can effects (or their influence) be established on the medical procedures?Are there statements available about costs and cost effectiveness?Are there recommendations for further use of the guidelines?

3. Medical Assessment
---------------------

### 3.1 Methodology

A systematic literature search was done in appropriate databases: in ME90, ME0A, SM78, CA66, CB85, BA70, EM90, IS74, EB94, IA70, AZ72, CV72, GE79, HN69, ED93, EA08, CCTR93.

The keywords were: Hypertonus, high blood pressure, guideline, guideline, Germany, German, health system, health service, hypertension, high blood pressing aurochs, guide line, practice guide line, Germany, German. The results of this literature enquiry are presented in the appendix of the complete report.

29 articles are considered in this HTA report, which directly deals with the high blood pressure guidelines or articles with a direct reference to the topic.

Articles were excluded which dealt with medical studies of the syndrome of hypertension without a direct reference to guidelines. Excluded as well was all literature concerning screening or methods of prevention and works concerned with putting guidelines into action.

### 3.2 Results

Currently, there are only few articles available for the German health services which deal with the actual effect of the Hypertension guidelines. The reason for the lack of literature regarding the guidelines should not be misinterpreted to indicate a lack of necessity. The benefits of the development of said guidelines have already been indicated in this report. It is far more likely that the methodical challenge of evaluating the lasting effects of the application of hypertension guideline is and has been more of a deterrent to the generation of any substantial amount literature.

#### 3.2.1 Scientific bases for the hypertonus treatment

Already on the literature search and checking the publications to the topic it turns out that the background of the implementation and evaluation of a guideline also should be considered systematically. According to evidence oriented development of guidelines the underlying therapeutic problem should be precise since these facts are examined in so-called intervention studies.

Controlled clinical long-term studies are intervention studies which are planned prospectively over a longer time period (al number of years) and two or more regimen can be compared with each other. The study can be designed open, simple or double blinded. The allocation of the patients should be randomised for reasons of comparability. Targets of intervention studies from the cardiovascular diseases are usually so-called \"hard\" end-points like mortality, total number of cardiovascular events or certain individual events and not so-called surrogate parameter (substitute parameter) like lowered blood pressure.

#### - Intervention studies to 1999

The reduction of the mortality due to high blood pressure and the subsequent diseases was the first priority in the studies to 1999. The risk of the hypertensive is increased morbidity (e.g. appearance of stroke or cardiac insufficiency) and mortality.

It could be shown in studies \[[@R24]\] that with a small patient group (n = 73) a drastic reduction of fatal and non fatal high blood pressure complications is possible for Hypertonus (VA-Study I). The VA-Study II \[[@R24]\] also yielded a clear reduction of the cardiovascular total morbidity and mortality without reducing the coronary mortality specifically.

The largest two studies were the British Medical Research Council Trial (MRC) \[[@R24]\] with over 17,000 patients and the American \"Hypertension Detection and Follow up Program\" (HDFP) \[[@R24]\] with over 10,000 participants. For the third study the number of participants could not be identified.

The dominant therapy principles of the 80\'s, the diuretics and beta blockers were compared into four studies. While two studies (IPPPSH \[[@R24]\] and HAPPHY \[[@R24]\]) were not showing any significant differences, beta blockers were in the MRC-Study \[[@R24]\] diuretics more successful in the prevention of strokes and in the MAPHY-Study \[[@R24]\] in the reduction of the complete and cardiovascular mortality.

#### - Intervention studies in the 90\'s

Due to the data situation at the hypertonus, several authors carried out a metaanalysis of the intervention studies of the elderly. In agreement with other authors, Holzgreve and Middeke \[[@R11]\] conclude that \"therapy of high blood pressure is around the factor 5 to 10 more successful with elderly patients than the treatment of younger patients, measured in terms of the avoidance of absolute events.\"

#### - Intervention studies with newer antihyperensive agents

First intervention studies with newer antihypertensive agents were introduced within the last few years \[[@R24]\].

The Chinese STONE-Study (Shanghai Trial of Nifedipine in The Elderly) showed a clear removal of cardiovascular events by 59% and the risk for stroke at 55% under a treatment with the retarded dihydropyridin calciumantagonist Nifedipin.

With the SYST EUR Study\* (Systolic Hypertension in Europe Trial) the second study has been submitted especially to the isolated systolic hypertonus for the treatment. This study was the first double blinded randomised trial with a calciumantagonist as a primary therapy, the long effective Dihydropyridin Nitrendipin. A diminution of the strokes by 42% was observed already after a follow-up period of two years in average. The total number of cardiac events were reduced by 26%, the cardiovascular mortality significantly by 27%, but not statistically significant.

The SYST study of China drew similar conclusions to the treatment of the isolated systolic hypertonus: Primary therapy should be done with Nitrendipin, a possible combination with Captopril and/or hydrochlorothiacide. After three years 38% less strokes, 37% less cardiovascular events and also to a significant reduction of complete mortality by 39% was observed in the group treated with Nitrendipine.

Newer antihypertensive agents were examined in comparison with the classic diuretical substances and beta blockers into two studies. The TOMHS-Study\* (Treatment of mild Hypertension Study) showed essential differences between diuretics (Chlortalidone) beta blockers (Acebutolol) calciumantagonist (Amlodipin), ACE inhibitors (Enalapril) and alpha blockers (Doxazosin) in the treatment within the period of four years. This concerned a blood pressure reduction, Lipid status, the development of the hypertrophy of the left ventricle with patients suffering from a mild hypertonus and a low risk and therefore a relatively rare appearance of cardiovascular complications. The medicinal treatment was more effective than a base therapy with a general treatment.

The CAPPP-Study\* (Captopril Prevention Project) compared the treatment with the ACE inhibitor Captopril with over 10,000 hypertonic patients in Scandinavia with the treatment with the classic antihypertensive substance classes of beta blocker or diuretics. Altogether, both therapeutic regiments had the same effectiveness in the avoidance of cardiovascular events and deaths as well.

#### - Studies results in connection with guidelines

The current German recommendations demand not only the blood pressure reduction or in the ideal case normalization of the blood pressure, but also that the antihypertensive therapy shall avoid high blood pressure complications and a reduction of damages of the target organ. According to the recommendations Diuretics, beta blocker, Calcium antagonists, ACE inhibitors and alpha blockers have the same position in the primary monotherapy. \"Methodically faultless long time trials for at least a year with several thousand patients\" are demanded besides the blood pressure lowering effect and subjective compatibility \[[@R24]\].

Over ten such studies for diuretics and beta blockers were available following these criteria at the time the publication, a study for Dihydropyridin-Calciumantagonist (Nitrendipin in SYST EUR) and no study was available for ACE inhibitors and alpha blockers (autumn 1998) according to a study of Trenkwalder \[[@R24]\]. A long-term study was available (CAPPP) for ACE inhibitors meanwhile, too; the data situation shows that the evidence for an use of the alpha blocker according to hard criteria still insufficient.

#### - Recommendations of the Joint National Committee \-- the JNC-VI report (the USA)

The JNC-VI report also takes the results of the intervention studies into account. Diuretics or beta blocker are recommended for the treatment of the \"uncomplicated\" hypertonus because of the numerous intervention studies on hand at the choice of the substances for the primary therapy. In further development of the often criticised JNC-V guidelines there are clear (\"mandatory\") reasons for use of newer antihypertensive agents like ACE inhibitors or calziumantagonists in the new report (type l diabetes, isolated systolic hypertonus with proteinuria, cardiac insufficiency). Especially low-dosed, pharmacological important combinations e.g. with low dosed diuretics or between ACE inhibitors and calcium antagonists are appreciated.

#### - Effects on the high blood pressure therapy in the daily practice

Examples: Calciumantagonists particularly were used frequently in the 80s and beginning of the 90s, although end no long-term studies were available with this substance class at this time. On the other hand there is an exaggerated restraint after the worldwide discussion concerning safety of short effective calciumantagonists at present. In addition, turns contrary to the therapy recommendations for reasons of cost still often perhaps- short change effectiveness and effective forms of Nifedipin and Verapamil used quickly, instead of changing to modern retard galenics of these active agents or pharmacologically long effective calciumantagonists.

Better compatibility for years stands out a constant fall in the prescription figures at the diuretics despite the good data situation with numerous intervention studies and this one at a low dosage. A similar trend is seen with the beta blockers although the data situation seems also here to be good primarily at parallel existing coronary heart disease or tachycardic heart rhythm disturbances.

Not only the choice of the antihypertensive agents, also the defined target blood pressure values (e.g. \<140/90 mm Hg) and the achievement of these blood pressure values still leave to be desired in Germany, Europe and America.

#### 3.2.2 Requirements on a hypertonus guideline

A Hypertension guideline should describe the underlying concepts and measures promoting compliance with regard to the evaluation of treatment of the hypertension. Specific goals would be as follows:

Reduction in the morbidity and mortality,Reduction in the therapy costs,Improvement of the quality of life,Reduction of accompanying risk factors.

The guideline should describe well-founded practise: Frequency/type of the measures for the supervision of illness course/treatment success (case history, use of laboratory and technical diagnostics) and to be more precise with different patient groups as well as after reaching the target values.

Particularly the position of structured follow-up concepts (inclusive of the integration of other health professions in the health service) should be evaluated. The following aims should be considered \[[@R5]\]:

Compliance with the medication,Reduction in the blood pressure values,Reduction in the morbidity (\"hard\" end-points like coronary heart disease or apoplex; as well as \"soft\" end-points: Final organ damages like eye participation, hypertrophy of the left ventricle, kidney participation without dysfunction),Reduction in the mortality,Improvement on the quality of life,Treatment costs.

Zidek \[[@R28]\] describes the new high blood pressure guidelines and states that the World Health Organisation (WHO) already 1999 created a new definition of hypertonus and published also a new guideline in cooperation with the International Society of Hypertension (IHS) for the diagnosis and treatment \[[@R4]\].

#### - German guidelines to high blood pressure

This year, the German high blood pressure league will return also new hypertonic guidelines which take the international development into account in essential points in this field. The essential, practically realisable innovations are explained in the following.

The following therapy strategies are used at the medicinal treatment of hypertonus:

Step therapy (\"stepped care\"): Start with monotherapy and add another antihypertensive agent in case of an insufficient effectiveness.Primary combination therapy with a low dosage: Due to the current results initial monotherapy of the hypertonus can be seen as equivalent to a beginning therapy with a combination of low dosed therapy of a diuretic agent plus ACE inhibitors or a diuretic agent plus a beta blocker with regard to effectiveness and side effects. A fix combination has the advantage of a higher compliance and often of also lower costs. The free combination permits naturally an individual dose customisation of both components.Sequential monotherapy, i.e. the antihypertensive agent is exchanged if necessary for other substances into monotherapy until an effective blood pressure reduction takes place.

For the choice of the therapy strategy blood pressure height, accompanying illnesses besides effects and compliance play an essential role. Positive aspects for a primary combination therapy are a blood pressure far above the target values as well as a co-morbidity which anyway make a combination therapy seem desirable (e.g. coronary heart disease, cardiac insufficiency, kidney insufficiency).

#### 3.2.3 Development of the guideline

Litteljohns et al. \[[@R15]\] give a summary of the European development of guidelines in Europe. The overview worked out in connection with AGREE Collaboration Group has recognised that the development of the guideline is strictly harmonised in the most important states of Europe. The individual countries do not develop only guidelines as an isolated action but within an environment of the organisational anchorage, distribution and system control.

Kunz and Pientka \[[@R12]\] deal with the role of the evidence based guidelines in Germany. The strategies are discussed, how guidelines ideally are developed in which form to be implemented in a health system. German guidelines to the hypertonus were published by the AWMF (work community of the scientific medical subject companies) and can be downloaded under the web address <http://www.awmf-leitlinien.de> in the full text.

#### 3.2.4 European perspective

#### - German guidelines for hypertonus

The therapy strategies are used like described:

The following aims are primary focussed:

Reducing the age dependent blood increase in pressure by a preventative behaviourLowering the prevalence of hypertonusImproving the recognition of the hypertonus in the populationIncreasing the effectiveness of the treatment of hypertonusReducing the cardiovascular complete riskInfluence still normal \"blood pressure values (130-139/85-89 mm Hg) \" with certain patient groupsUsing not medicinal possibilities (change of the lifestyle) more than so far.

The guideline contains much detail information about diagnostics, indication position, therapy, risk stratification, subsequent and accompanying illnesses, information about diagnosis and therapy of certain target groups.

#### - Other European perspectives

Zidek \[[@R29]\] describes the recommendations of the European Society for Hypertonus (ESH) for the high blood pressure treatment with regard to the classification and risk stratification. With the recommendations of the ESH and the ESC Hypertonus guidelines have been published for the first time for Europe. In the European guidelines the characteristics of the European population is taken into account as opposed to the American recommendations. Features like stronger homogeneity, higher life expectancy but also higher incidence of cardiovascular illnesses are included.

The idea of the \"Pre-Hypertonus\" is introduced in the JNC recommendations (QNC = Joint National Committee on Prevention and Control of Hypertension): Persons with a systolic blood pressure value between 120 and 139 mm Hg and/or diastolic blood pressure values between 80 and 89 mm Hg are considered as \"Pre-hypertonics\" and should be advised to the prevention of cardiovascular illnesses including health promoting \"Life-style\".

The previous limiting values of the German recommendations are higher than the values of the European guidelines published newly. In Germany only values which are higher than 130 mm Hg systolic and 80 mm Hg diastolic are considered as suffering from hypertension whereas the European guidelines consider hypertonus at a level of measuring a 24 hour blood pressure and start at a level of 125/80 mm Hg.

The risk stratification as a basis of the decision is also unchanged for or against a medicinal antihypertensive therapy. Several criteria are the basis of the risk stratification: The further cardiovascular risk factors (e.g. hypercholesterinaemia or nicotin abuse) as well as the evidence of hypertonus induced organ changes (e.g. a hypertrophy of the left ventricle or nephropathy) are included. A risk factor added newly is an increased C reactive protein (CRP), and this also belongs to the cardiovascular risk factors now. Focal vessel narrowing at the eye background is not valid any more than hypertonus induced organ damages. More detailed changes at the eye background like bleedings, exudates or papilla oedemas are taken into account as an associated illness.

#### 3.2.5 Implementation of guidelines

Reinauer \[[@R20]\] sees the big problem nowadays less in the development of the guideline and the discussion with the critics than in the implementation of the guidelines to the service supply. The implementation \"of the guidelines is considered as the real problem by international experts. The guidelines must be made to the practising doctors available in suitable form and be introduced in the education and training. The fee system finally must adapt to the guidelines and this is task of the medical corporations. The expert advice (Sachverständigenrat) expressed clearly this problem in 1997, much has not happened, however, in opinion of the author.\"

The implementation strategy has led to new recommendations of the German \"Hochdruckliga\" \[[@R27]\] also in Germany.

McAlister and Padwal \[[@R18]\] deal with the question of which criteria are suitable to influence the medical decision finding. They see the following order of the criteria:

colleagues or local opinion leaders,review articles,textbooks,experience.

On the other hand it is not plausible that the marketing strategies of the pharmaceutical industry orientated to profit should be ineffective although most clinicians shall claim the advertising strategies of the pharmaceutical industry should not be able to influence the decision making process. The authors emphasise, that it is not clear due to the contemporary science whether guidelines are able to influence the practice. A review of 87 comparable studies shows that 5 out of 13 guidelines could improve the actual result parameters of the patients in the primary supply \[[@R8]\], \[[@R26]\].

As barriers for the successful putting into action of hypertonus guidelines the authors see clinical barriers, environment conditioned factors (lacking incentives), patient barriers as well as barriers due to the guideline itself (knowledge, simplicity, heterogeneity of different guidelines etc. \[[@R18]\], \[[@R3]\].

#### 3.2.6 Guideline knowledge

Schneider et al. \[[@R21]\] dealt with the knowledge of internists and general doctors in detail with the contents of the guideline to the arterial hypertonus.

The authors assume only a low portion of patients are treated sufficiently against arterial hypertonus. A possible explanation for this circumstance is that the physicians do not have sufficient knowledge of arterial hypertonus. There is a huge body of scientific knowledge and this information in addition to further educational offers concerning the arterial hypertonus, but the active knowledge of a physician is often very poor about this topic. The documentation of the level of knowledge of a doctor to a specific topic is, however, a basic prerequisite to judge the medical supply quality and perhaps also the basis for recommending consequences for achieving the medical standard.

In published articles the state of knowledge of internists and general doctors was checked concerning diagnostics topics by questionnaire. 23.7% (n=2,739) had a sufficient knowledge of the therapy of the arterial hypertonus related to the complete collective of the doctors (n=11,547); the subgroup of the general practitioners 803 out of 4,262 (18.8%) doctors pointed an adequate knowledge of the guideline, the knowledge the internists was higher with 26.6% (1,936 out of 7,285).

#### 3.2.7 Therapy of the arterial hypertonus

Wenzel et al. \[[@R2]\] ran a survey to get information concerning the real form of therapies of hypertonus with 1,540 physicians. The number of possible antihypertensive agent is large. National and international committees regularly publish recommendations for the antihypertensive therapy. It is not known, however, really how physicians choose the therapies.

1,540 physicians in Hamburg were asked by questionnaire, 458 (30%) of internists and general practitioners answered concerning the therapy advices of arterial hypertonus.

The results were: 38% of the people asked regarded a medicinal therapy as required at a blood pressure of 140/90 mm Hg. 52% stated, only values of above 160/95 mm Hg and 10% even only with levels of higher than 180/100 mm Hg need a therapy. Internists tend to a more \"aggressive\" therapy than general practitioners. An efficient blood pressure reduction (95%), few side effects (83%) and a reduction in the morbidity and mortality (44%) are considered as the most important qualities of a good antihypertensive agent in different studies. The three at the most frequent used substance classes of antihypertensive agent were ACE inhibitors (98%), followed by beta receptor blockers (86%) and diuretics (60%). Calciumantagonists (54%) and AT 1 blockers (22%) followed on fourth and fifth rank.

#### - Conclusion

The study shows doctors give therapy to the arterial hypertonus in accordance with the official recommendations and guidelines. However, there is a further education need at the definition of normotensive blood pressure values and improvements are still possible with the therapy of comorbidity like diabetes mellitus, coronary heart disease and kidney diseases.

#### 3.2.8 Compliance of the doctors

The readiness of the doctors to resurrect the guidelines practically also can be considered a quite essential part of the cascade of science up to the improved practice.

Seddon et al. \[[@R22]\] describe the quality of the medical supply in an overview work in which the compliance with guidelines is considered as one of the central criteria. Table 1 [(Tab. 1)](#T1){ref-type="fig"} shows a complete representation of the results of this work for the high blood pressure. Altogether eleven articles were included, ten from Great Britain, one from Australia.

The compliance of the practitioners with the guidelines can be seen in this table.

The factors obtained from another study focused on the dominant role of the practitioner for the compliance both by his influencing on the attitude of the patients for the high blood pressure treatment and by the way of prescription \[[@R25]\].

#### 3.2.9 Compliance of the patients, training

According to Heise et al. \[[@R10]\] a main reason for the poor quality of blood pressure control could be in the lacking compliance of doctors and patients. The therapeutically interventions are proven to be effective.

After studies of Lüscher et al. \[[@R17]\] up to 40% of the patients do not take the prescribed medicine, mostly due to side effects which are (appeared really or feared merely) \[[@R13]\], \[[@R14]\]. An improvement in the cooperation is of decisive importance between doctors and patients.

The solution of this problem could most likely be achieved by the active inclusion of the patient in his treatment with informing about the treatment possibilities and with own control of the therapy success by the correct self measuring of the blood pressure. Such structured therapy and training programmes provide a standard to be not spirited away anymore in the treatment of the diabetes mellitus \[[@R1]\] which is already implemented into the basic support of many health systems meanwhile \[[@R2]\], \[[@R8]\]. The role of the required patient training is discussed by Stolte \[[@R23]\]. For Stolte the addressee of the guidelines is particularly the practitioner when treating high blood pressure suffering patients. The specialists are addressed firstly as well as the general practitioner. The guidelines should be concise and mustn\'t have the size of a little textbook of the arterial hypertonus when they are read and implemented.

#### 3.2.10 Measuring of the practical significance of guidelines

The measuring of the practical significance represents a challenge for evaluation research. To be able to operationalise this phenomenon, Dykes \[[@R6]\] indicates some methodical aspects in the article. For the successful evaluation the compliance with the criteria indicated in the following list is necessary:

patient selectionbase riskduration models for the results being interestedtime varying models for dependent variablesmeasuring of the compliance with the guidelines.

#### 3.2.11 Results of the evaluation of the programme

Trainings represent an essential part of the successful implementation of the guidelines. A certain training programme was therefore subjected to an evaluation. The introduced hypertonus treatment and training programme (HBSP) was evaluated in several prospective controlled studies by different patient groups which shall be presented here.

Essentially, hypertonus is carried out mainly in the outpatient setting, this setting was evaluated in the long run \[[@R4]\], \[[@R17]\]. The project had three phases. The blood pressure measuring was standardised by a three-hour blood pressure-measuring course in accordance with the guidelines of the German league for the reduction of high blood pressure (Deutsche Hochdruckliga) in all participating practices in the first phase which both the physicians and the medical assistance personal. After that the HBSP was introduced in five of the ten participating practices, the groups were randomised. The other five practices were instructed to look after her patients of hypertonus without the HBSP but in the best possible way. For the evaluation in each of the ten practices 20 hypertonic patients were selected with unchecked blood pressure values according to randomness. These patients were then tested by an examination of the documentation after one, five or three years in the second and third phase of this study.

After encouraging intermediate results after 1.5 years \[[@R16]\] a median blood pressure reduction of 9 mm Hg after three years \[[@R17]\] with the 74 after examined patients of the five HBSP practices in opposition to 3 mm Hg with the 67 registered patients from the five control practices could be achieved (p\< 0.05). The number of the prescribed antihypertensive per patient declined despite the stronger blood pressure reduction in the HBSP group while it was rising for the patients treated conventionally.

#### 3.2.12 Target achievement of guidelines

Implementation and putting into practise of guidelines shall cause an improvement on the target disease in the population. It is therefore inevitable to evaluate the success of the target of the respective guideline.

The target achievement of high blood pressure guidelines was investigated in a quasi experimental before-after design of the Joint Commission \[[@R19]\]. Criteria were: Blood pressure levels, pre-guideline (before the guideline) versus post-guideline (according to the guideline); (systolic blood pressure of (SBP) \<140, diastolic blood pressure of (DBP) \<90). Comparison variables included SBP \<140 mm Hg measured in terms of the highest value, SBP \<140 mm Hg measured in terms of the lowest value; DBP \<90 mm Hg measured in terms of the highest value, DBP \<90 mm Hg measured in terms of the lowest value lead to significant differences between before and after the application of the guideline in respect to shares of patients achieving the therapy target.

4. Summarising discussion of all results
----------------------------------------

There is a large number of single results which shall be processed to a coherent overall impression. The questions can be answered in particular:

How much are the guidelines used concerning hypertension?Can effects (or their influence) be established on the medical procedures?Are there statements available about costs and cost effectiveness?Are there recommendations for further use of the guidelines?

Ad 1: You can assume that the known guidelines concerning hypertonus are basically used. The practitioners nowadays have a higher level of knowledge than in the past.

Ad 2: Consequences for the German health system are only predictable indirectly with the literature available. From international investigations the partly big difference between before and after a training programme concerning guidelines is known. Guidelines are action leading also for medical behaviour to an increasingly stronger extent. This knowledge can not be derived directly from the investigations, but when analysing a large number of appropriate articles one can get this impression. These facts are not indicated in the individual studies with this directness since guidelines were considered also in the context of a restriction of the freedom of therapy of practitioners. This circumstance of the possible restriction of the freedom of choice of the medical therapy is a problematic topic.

Ad 3: There is practically no relevant economic investigation about the use of the guidelines for the treatment of hypertonus. Health economically no analysis could be found which directly addresses the efficiency of the construction, distribution or use of the guideline.

Ad 4: In principle, guidelines cover the complete range of the illustration of the current scientific knowledge about the treatment up to the development control, the integration of the patient, further to the documentation, and therefore they are an essential factor for the arranging of the medical practice. The increased attention of the hypertonus guideline in the individual practice can lead to a further application of the guideline but probably not to an increased amount of \"laws\" which could be considered as restrictive for a confidential doctor/patient relationship. Therefore there is not one hint in the literature, that this guideline should not be developed further, that the charges are not justifying the effort or that these would be ineffective. Exactly the opposite seems to be true. The further application, implementation and increased distribution of the contents of the guideline can therefore be supported from the view of the literature, which is not arguing very accurately.

5. Conclusion
-------------

Guidelines represent an important instrument in the arranging of the medical practice. Guidelines independently give information and \"safety\" to the knowledge of the exact contents in the field of treatment of selected morbidity. This applies as well to the hypertonus guideline here being under discussion.

The evidence and the general situation for answering the question is very unsatisfactory in the current range of publications. Despite the numerous indirect notes about the positive effect of the guideline it would be desirable that there should be more empirical studies concerning the effect of the guideline on the level of knowledge, the safety in the procedure or the sustainability of the compliance with the therapy recommendations in Germany.

The finding in this report derives out of publications which are partly older than ten years, some conclusion is made of comparing from foreign examinations and partly from similar questions like guidelines from other topics. Since there was no single investigation which directly addresses at least parts of the questions, therefore there is a need for action for primary research.

Following current state of knowledge the guidelines should be developed further \-- also the hypertonus guideline. Guidelines have the task to represent the knowledge on a high level of acceptance, because a large number of experts are part of the process of development (step 2 level of the hypertonus guideline means: formal evidence enquiry or formal consensus finding).

The distribution and continuously further use can be recommended therefore very well and this is also according to the mainstream of thinking medicine.
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